Trumps Disloyal Label Threatens Cornyns Senate Career Amid Record Ad Spending Retail Sales Defy Consumer Pessimism How Long Can the Paradox Last Yahoo Finance Releases Best Private Student Loans for May 2026 What Borrowers Should Know USIran Deal Progress Could Reshape Geopolitical Landscape Oil Markets Nvidia Earnings in Focus Geopolitical Commentary on China and Trade Could Influence Markets TSMC Stock Flirts with Buy Point as Chip Giant Plans Price Hike Amid AI Demand IFS Q1 2026 Earnings EPS Surpasses Estimates by 1095 Amid Broader Market Headwinds MITK Q1 2026 Earnings EPS Surpasses Estimates on Strong Operating Performance YOU Q1 2026 Earnings EPS Beats Estimates by 12 but Stock Declines Despite Profit Surprise TIC Solutions Inc Q1 2026 Earnings Deep EPS Miss Highlights Ongoing Cost Pressures AVGO Q1 2026 Earnings Narrow EPS Miss Amid Modest Market Response TRU Q1 2026 Earnings Strong EPS Beat Drives Investor Optimism Microchip Technology Preferred Shares MCHPP Rally 448 as Market Sentiment Improves Mineralys Therapeutics MLYS Holds Steady Near Resistance as Volume Remains Muted Diamondback Energy FANG Holds Steady Near Key Resistance as Energy Sector Shows Mixed Signals Armada Acquisition Corp II XRPN Holds Steady at 1039 Amid SPAC Market Dynamics AgEagle Aerial Systems UAVS Surges 5 as Drone Plays Rebound from Support Jamie Dimon Signals JPMorgan Chase Could Pursue 20 Billion Acquisition Acknowledges Regulatory Hurdles CarPartscom PRTS Q1 2026 Earnings EPS Beat Despite Challenging Environment Capital City Bank Group CCBG Holds Steady Amid Modest Decline Key Levels in Focus MTUS Q1 2026 Earnings EPS Surpasses Estimates by 1765 Comstock Inc LODE Q1 2026 Earnings Narrower Loss Beats Expectations Stock Rises FLEX LNG Q1 2026 Earnings EPS Miss Weighs on Shares as LNG Market Headwinds Persist Atkore ATKR Q1 2026 Earnings EPS Beats Estimates by 139 Amid Operational Strength URG Q1 2026 Earnings Wide EPS Miss as Development Continues Stock Edges Higher AFRM Q1 2026 Earnings EPS Beat Drives DoubleDigit Stock Rally CRVS Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Continues Pipeline Progress